An Exploratory, Open-Label Phase I Pharmacodynamic Study of COX-2 Inhibition With Celecoxib (Celebrex) and Aromatase Activity in Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Jun 2010 Results presented at ASCO 2010.
- 30 Mar 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.